2 completed, 1 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow D: new trials by email Literature Review of D trials Research Report on D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SVRd for the Treatment of Newly Diagnosed Multiple Myeloma Patients Presenting With Extramedullary Disease Selinexor, Bortezomib, Lenalidomide - Multiple Myeloma | Phase 2 | Completed | The First Affiliated Hospital with Nanjing Medical University | 29 | 2022-07-15 | 2026-09-02 |
| Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DIC 5-fluorouracil, Docetaxel - Gastric Cancer, Bone Marrow Metastasis | Phase 2 | Completed | Sixth Affiliated Hospital, Sun Yat-sen University | 24 | 2021-01-15 | 2024-03-25 |
| Intensity-modulated Radiotherapy With Integrated-boost in Patients With Spinal Bone Metastases A, B, C - Vertebral Bony Metastases | Phase 2 | Unknown | Heidelberg University | 120 | 2016-09-01 | 2016-07-14 |
Disseminated Intravascular Coagulation (1) · Multiple Myeloma (1) · Stomach Neoplasms (1)
Heidelberg University (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (2) · Germany (1)
Jian Xiao, MD (1) · Lijuan Chen (1)
PMID 22172095, PMID 23052695, PMID 23101946, PMID 24890347, PMID 29357902, PMID 36346044, PMID 41564431